Biogen Idec Ma Inc.

Althea Technologies, Inc.

Allena Pharmaceuticals, Inc.

Apoxis S.a.

Ajinomoto Althea, Inc.

Biogen Ma Inc.

Teresa G Cachero

Bhami Shenoy

John J Shin

Margaret Ellen McGrath

Reena J Patel

Danica Grujic

Lekai Zhang

Aftab Rashid

Paul David Rennert

Christine Ambrose

Jeffrey Thompson

Pascal Schneider

Bhami C Shenoy

Jeffrey S Thompson

John Shin

Margaret Ellen Mcgrath

Paul D Rennert

Oxalate decarboxylase crystals, including stabilized crystals, such as cross-linked crystals of oxalate decarboxylase, are disclosed. Methods to treat a disorder associated with elevated oxalate concentration using oxalate decarboxylase crystals are also disclosed. Additionally disclosed are methods of producing protein crystals.

Crystallized oxalate decarboxylase and methods of use

A novel receptor in the TNF family is provided: APRIL-R. Chimeric molecules and antibodies to APRIL-R and methods of use thereof are also provided.

Methods of treating a tumor that expresses APRIL by administering BCMA

A newly identified heteromeric ligand of the Tumor Necrosis Factor (TNF)-family, referred to hereinafter as 'APBF' has been identified.

Heterologous polypeptide of the TNF family

Growing community of inventors

Hingham, MA, United States of America

Teresa G Cachero